Published in Acta Ophthalmol on November 01, 2009
A case series of neuroendocrine (carcinoid) tumor metastasis to the orbit. Oman J Ophthalmol (2011) 0.75
Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am (2005) 2.24
Choroidal biopsies for intraocular tumors of indeterminate origin. Am J Ophthalmol (2005) 1.87
Photochemical damage of the retina. Surv Ophthalmol (2006) 1.83
Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study. Ophthalmology (2012) 1.78
Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Arch Ophthalmol (2011) 1.78
Ligneous conjunctivitis. Surv Ophthalmol (2003) 1.59
Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand (2006) 1.47
Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. Invest Ophthalmol Vis Sci (2002) 1.33
Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Ophthalmology (2005) 1.32
Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol (2004) 1.20
Molecular and clinical spectrum of type I plasminogen deficiency: A series of 50 patients. Blood (2006) 1.20
Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study. Ophthalmology (2012) 1.15
Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. Invest Ophthalmol Vis Sci (2003) 1.14
The cut-and-paste method for primary pterygium surgery: long-term follow-up. Acta Ophthalmol Scand (2005) 1.12
The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Clin Cancer Res (2006) 1.09
Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation. Cell Mol Life Sci (2013) 1.08
Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci (2002) 1.08
Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor. Invest Ophthalmol Vis Sci (2008) 0.99
Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma. Cancer (2010) 0.98
Expression and prognostic significance of iNOS in uveal melanoma. Int J Cancer (2010) 0.96
A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations. Acta Ophthalmol (2007) 0.96
Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice. Exp Eye Res (2005) 0.95
c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target? Invest Ophthalmol Vis Sci (2004) 0.95
Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor. Proc Natl Acad Sci U S A (2012) 0.94
Age-related maculopathy: pathogenetic features and new treatment modalities. Acta Ophthalmol Scand (2002) 0.93
Uveal melanoma: a study on incidence of additional cancers in the Swedish population. Invest Ophthalmol Vis Sci (2006) 0.92
Oncocytoma of the lacrimal gland. Acta Ophthalmol Scand (2007) 0.91
Intraoperative mitomycin C versus autologous conjunctival autograft in surgery of primary pterygium with four-year follow-up. Acta Ophthalmol (2010) 0.91
To biopsy or not to biopsy? Acta Ophthalmol (2009) 0.90
Structure and function of the N-cadherin/catenin complex in retinoblastoma. Invest Ophthalmol Vis Sci (2002) 0.89
Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications. Invest Ophthalmol Vis Sci (2005) 0.89
Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma. Invest Ophthalmol Vis Sci (2008) 0.89
Subthreshold transpupillary thermotherapy reduces experimental choroidal neovascularization in the mouse without collateral damage to the neural retina. Invest Ophthalmol Vis Sci (2004) 0.88
Fine-needle aspiration cytology and immunocytochemistry of orbital masses. Diagn Cytopathol (2006) 0.88
A prospective study of children treated for retinoblastoma: cognitive and visual outcomes in relation to treatment. Acta Ophthalmol Scand (2002) 0.88
Topical chemotherapy for ocular surface squamous neoplasia: current status. Br J Ophthalmol (2009) 0.87
Mantle cell lymphoma of the iris. Acta Ophthalmol Scand (2007) 0.86
Uveal melanoma survival in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci (2003) 0.86
Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications. Acta Ophthalmol (2008) 0.85
Photodynamic therapy for circumscribed choroidal haemangioma. Acta Ophthalmol Scand (2002) 0.83
Transpupillary thermotherapy of predominantly occult choroidal neovascularization in age-related macular degeneration with 12 months follow-up. Acta Ophthalmol Scand (2003) 0.83
JARID1B protein expression and prognostic implications in uveal melanoma. Invest Ophthalmol Vis Sci (2012) 0.82
Nuclear HER3 is associated with favorable overall survival in uveal melanoma. Int J Cancer (2011) 0.82
Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity. Br J Ophthalmol (2012) 0.80
Malignant solitary fibrous tumour of the orbit. Acta Ophthalmol (2008) 0.80
Combination therapy with low-dose transpupillary thermotherapy and intravitreal ranibizumab for neovascular age-related macular degeneration: a 24-month prospective randomised clinical study. Br J Ophthalmol (2012) 0.79
The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Acta Ophthalmol (2008) 0.79
Retinal vascular development and pathologic retinal angiogenesis are not impaired in matrix metalloproteinase-2 deficient mice. Curr Eye Res (2005) 0.79
Vision-related function after low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration. Acta Ophthalmol (2010) 0.79
Photoreceptor survival in transplantation of autologous iris pigment epithelial cells to the subretinal space. Acta Ophthalmol Scand (2002) 0.79
TIMP-3 mRNA is not overexpressed in Sorsby fundus dystrophy. Am J Ophthalmol (2003) 0.78
Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin(®) ). Acta Ophthalmol (2010) 0.78
Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor. Acta Ophthalmol (2008) 0.78
Uveitis masquerade syndromes: diffuse retinoblastoma in an older child. Acta Ophthalmol Scand (2007) 0.77
Safety of irrigation with 5-fluorouracil in a sealed-capsule irrigation device in the rabbit eye. J Cataract Refract Surg (2007) 0.77
Intravitreal bevacizumab in central retinal vein occlusion: 18-month results of a prospective clinical trial. Eur J Ophthalmol (2011) 0.77
Primary transpupillary thermotherapy of "small" choroidal melanoma: is it safe? Br J Ophthalmol (2008) 0.77
Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss? Acta Ophthalmol Scand (2003) 0.76
Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma. Acta Ophthalmol (2008) 0.76
Who's the faster runner: the cheetah or the rabbit? Acta Ophthalmol (2009) 0.75
Shall we use Avastin or Lucentis for ocular neovascularization? Acta Ophthalmol (2008) 0.75
Dystrophia Smolandiensis: a novel morphological picture of recurrent corneal erosions. Acta Ophthalmol (2009) 0.75
Detection of diabetic retinopathy: a comparison between red-free digital images and colour transparencies. Graefes Arch Clin Exp Ophthalmol (2004) 0.75
Gullstrand's Nobel Prize. 100 years and counting. Acta Ophthalmol (2011) 0.75
Malignant melanoma of soft parts arising from Tenon's capsule. Acta Ophthalmol (2009) 0.75
Nordic research in ophthalmology. Acta Ophthalmol Scand (2005) 0.75
Characterization of plasminogen variants in healthy subjects and plasminogen mutants in patients with inherited plasminogen deficiency by isoelectric focusing gel electrophoresis. Thromb Haemost (2004) 0.75
EJO talks to Stefan Seregard, President of the European Society of Ophthalmology, about the SOE 2015 congress and what makes the SOE congress so unique. Eur J Ophthalmol (2015) 0.75
Swedish ophthalmology faces up to the 21st century. Acta Ophthalmol (2008) 0.75
Angle involvement and glaucoma in patients with biopsy-proven iris melanoma: a response-reply. Arch Ophthalmol (2012) 0.75
Preoperative sub-Tenon's capsule injection of ropivacaine in conjunction with general anesthesia in retinal detachment surgery. Ophthalmology (2007) 0.75